Use of administrative data to estimate the incidence of statin-related rhabdomyolysis.
about
Phenotype standardization for statin-induced myotoxicityStudy of Cardiovascular Health Outcomes in the Era of Claims Data: The Cardiovascular Health StudyCombining structured and unstructured data to identify a cohort of ICU patients who received dialysis.Validation of methods for assessing cardiovascular disease using electronic health data in a cohort of Veterans with diabetes.Using linked electronic data to validate algorithms for health outcomes in administrative databases.Use of administrative data to increase the practicality of clinical trials: Insights from the Women's Health Initiative.Predictors and outcomes of increases in creatine phosphokinase concentrations or rhabdomyolysis risk during statin treatment.Is there a clinically relevant interaction between clarithromycin and statins not metabolized by cytochrome P450 3A4?Implications of the new American College of Cardiology/American Heart Association cholesterol guidelines for primary atherosclerotic cardiovascular disease event prevention in a multi ethnic cohort: Multi-Ethnic Study of Atherosclerosis (MESA)Incidence, etiology, and outcomes of rhabdomyolysis in a single tertiary referral centerUsing natural language processing to improve efficiency of manual chart abstraction in research: the case of breast cancer recurrence.Phenotyping Adverse Drug Reactions: Statin-Related Myotoxicity.Pharmacological management of diabetic dyslipidemia.The Application of Genomics in Diabetes: Barriers to Discovery and Implementation.Development and validation of algorithms for the detection of statin myopathy signals from electronic medical records.On the hypothetical universal use of statins in primary prevention: an observational analysis on low-risk patients and economic consequences of a potential wide prescription rate.Laparoscopic partial nephrectomy in a patient on simvastatin : Delayed recovery from neuromuscular blockade.Statin-associated myopathy. Assessment of frequency based on data of all statutory health insurance funds in Germany.Onset timing of statin-induced musculoskeletal adverse events and concomitant drug-associated shift in onset timing of MAEs
P2860
Q27020935-0B3A7296-6E7F-4308-911A-AA58C79925D9Q28601636-89BF8329-E2EA-40AB-A21D-EC0B3387D489Q30725122-56AC1C3B-AD0A-448A-9A04-60C3005C1136Q30740532-B8B0B7DC-A6C1-4B34-BEC7-4496B1413075Q30987366-3FA6DB0C-755A-42E6-9BFA-7AE0F19A1D3BQ31111666-85C277E8-70C7-4E42-882B-6CA0742B66A2Q34571112-46EFD148-B50C-4427-BB44-6188C60D36EDQ35088411-A89010A1-0E85-4063-B759-65E641565356Q35142002-18558D16-0683-437C-8891-E4952DE779BCQ37098094-516DA931-17A2-4FEF-9244-8BDD788D7744Q37612592-E0CE45C2-A248-41A9-99C3-1C40B6258E50Q38573568-3BE79863-7B4E-46D9-8F97-C99487C9EBFDQ39015072-8D22796E-742C-450D-8501-5D214EA29A01Q39123582-EF83B22D-A952-4D76-8EC4-8A75EE496454Q39319994-8859657D-F2F3-4BF4-99B6-2166E22A89CAQ41458408-0212A61E-608E-4D72-91C2-7227F04EC30EQ47323020-64FCFED9-8BF5-4647-BBE6-EB68A9E17E5AQ55129505-DC741CE2-C2B4-49BF-BF9A-12D83F99E7E3Q59133164-71195B8E-30EC-49AF-9950-240AEA0A3D1E
P2860
Use of administrative data to estimate the incidence of statin-related rhabdomyolysis.
description
2012 nî lūn-bûn
@nan
2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Use of administrative data to estimate the incidence of statin-related rhabdomyolysis.
@ast
Use of administrative data to estimate the incidence of statin-related rhabdomyolysis.
@en
Use of administrative data to estimate the incidence of statin-related rhabdomyolysis.
@nl
type
label
Use of administrative data to estimate the incidence of statin-related rhabdomyolysis.
@ast
Use of administrative data to estimate the incidence of statin-related rhabdomyolysis.
@en
Use of administrative data to estimate the incidence of statin-related rhabdomyolysis.
@nl
prefLabel
Use of administrative data to estimate the incidence of statin-related rhabdomyolysis.
@ast
Use of administrative data to estimate the incidence of statin-related rhabdomyolysis.
@en
Use of administrative data to estimate the incidence of statin-related rhabdomyolysis.
@nl
P2093
P2860
P356
P1476
Use of administrative data to estimate the incidence of statin-related rhabdomyolysis.
@en
P2093
David S Carrell
James S Floyd
Noel S Weiss
P2860
P304
P356
10.1001/JAMA.2012.489
P407
P577
2012-04-01T00:00:00Z